For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Erlangen D-91054

0 studies enrolling now · 11 studies all time

What they study most

Autoimmune Disease, Carcinoma, Hepatocellular, Carcinoma, Non-Small-Cell Lung, Connective Tissue Disease, Diabetes Mellitus, Type 2, Head and Neck Neoplasms, Non Hodgkin Lymphoma, Non Small Cell Lung Cancer, Prostate Cancer, Rheumatoid Arthritis, Sepsis, Systemic Lupus Erythematosus

Studies at this site

• A Study of LY2157299 in Participants With Hepatocellular Carcinoma — Completed
• A Phase 2 Study With Enzastaurin Plus Chemotherapy or Placebo Plus Chemotherapy for Prostate Cancer Patients — Completed
• Study of Human Insulin Inhalation Powder in Patients With Type 2 Diabetes — Completed
• A Study of Pemetrexed and Carboplatin/Cisplatin or Gemcitabine and Carboplatin/Cisplatin With or Without IMC-1121B in Participants Previously Untreated With Recurrent or Advanced Non-Small Cell Lung Cancer (NSCLC) — Completed
• PRELUDE:Study to Investigate the Prevention of Relapse in Lymphoma Using Daily Enzastaurin — Completed
• A Study of LY2127399 in Participants With Systemic Lupus Erythematosus — Completed
• An Open Label Study for Participants With Rheumatoid Arthritis — Stopped early
• A Study in Participants With Rheumatoid Arthritis — Stopped early
• Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer — Completed
• A Study for Patients With Head and Neck Cancer — Completed
• Investigation of the Efficacy and Safety of Drotrecogin Alfa (Activated) in Pediatric Severe Sepsis — Completed